Skip to main content

Alterity Therapeutics Ltd

ATHE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001131343

In the last 90 days, Alterity Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.12M in total; no superinvestor holds it.

Other share classesPRNAF

Superinvestors holding ATHE, Q2 2026

See all superinvestors

No superinvestor reported holding ATHE in Q2 2026.